Health Insurance Innovations Sees Prelim. Q4 Adj. EPS $2.30-$2.55 vs $2.37 Est., Sales $159M-$164M vs $172.37M Est.; Sees Prelim. FY19 Adj. EPS $4.10-$4.35 vs $4.14 Est., Sales $380M-$385M vs $393.1M Est.
Benzinga Newsdesk